Loss of HPV16 E2 Protein Expression Without Disruption of the E2 ORF Correlates with Carcinogenic Progression
Open Access
- 28 December 2012
- journal article
- Published by Bentham Science Publishers Ltd. in The Open Virology Journal
- Vol. 6 (1), 163-172
- https://doi.org/10.2174/1874357901206010163
Abstract
Loss of HPV16 E2 Protein Expression Without Disruption of the E2 ORF Correlates with Carcinogenic ProgressionKeywords
This publication has 25 references indexed in Scilit:
- Tumor suppressor or oncogene? A critical role of the human papillomavirus (HPV) E2 protein in cervical cancer progression.2011
- HPV16 E2 Is an Immediate Early Marker of Viral Infection, Preceding E7 Expression in Precursor Structures of Cervical CarcinomaCancer Research, 2010
- The Human Papillomavirus Type 18 E2 Protein Is a Cell Cycle-Dependent Target of the SCF Skp2 Ubiquitin LigaseJournal of Virology, 2010
- Transcriptional regulation of the papillomavirus oncogenes by cellular and viral transcription factors in cervical carcinomaVirology, 2009
- Papillomavirus DNA replication — From initiation to genomic instabilityVirology, 2009
- Papillomavirus genome structure, expression, and post-transcriptional regulationFrontiers in Bioscience-Landmark, 2006
- The X-ray structure of the papillomavirus helicase in complex with its molecular matchmaker E2Genes & Development, 2004
- Stability of the Human Papillomavirus Type 18 E2 Protein Is Regulated by a Proteasome Degradation Pathway through Its Amino-Terminal Transactivation DomainJournal of Virology, 2001
- Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes.1999
- Structure and transcription of human papillomavirus sequences in cervical carcinoma cellsNature, 1985